Vivera Pharmaceuticals

Vivera Pharmaceuticals has global exclusivity to license the patented and patent-pending TABMELT® sublingual delivery system for pharmaceutical use, and its own issued patents on ZICOH™, a smart dose-controlled medical device. It has patents pending on a telemedicine station, MDZone.


Headquaters
Vivera Pharmaceuticals, Inc
4343 Von Karman Ave Ste. 100
Irvine
CA 92660
United States

Phone / Contact

T: +1 844 484 8372

Vivera Pharmaceuticals has global exclusivity to license the patented and patent-pending TABMELT® sublingual drug delivery system for pharmaceutical use, and its own issued patents on ZICOH™, a smart dose-controlled medical device. It also has patents pending on its telemedicine station, MDZone.

With multiple divisions, including pharmaceutical, neuroscience, medical technology, bioscience and advanced diagnostics divisions, Vivera is vertically integrated with patented technology, manufacturing capabilities and distribution for its products.

Top